| Value | ₹10,000 Cr |
|---|
BSE filing, NSE: BPCL. Summary written from the filing by ALFA Finder's alert engine.
Bharat Petroleum Corporation Ltd: key numbers
- Share price
- ₹289.20
- Market cap
- ₹1,25,470 Cr
- Revenue (annual)
- ₹4,55,228 Cr
- Net profit (annual)
- ₹25,843 Cr
- P/E (TTM)
- 7.9×Sector 17.8×
- Promoter holding
- 52.98%+0.00% QoQ
- FII holding
- 16.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bharat Petroleum Corporation Ltd
All →Bharat Petroleum Corporation Credit Rating
Crisil reaffirmed or assigned credit ratings for Bharat Petroleum across bank facilities, NCDs and commercial paper. Ratings remain at the top AAA and A1+ grades.
Bharat Petroleum Corporation Debt & Borrowing: ₹3,000 Cr
BPCL confirmed full redemption of Rs.3,000 Crore Commercial Paper (INE029A14BZ9) at its 27 October 2026 maturity. Outstanding amount is now nil.
- Value
- ₹3,000 Cr
Bharat Petroleum Corporation Debt & Borrowing: ₹10,000 Cr
BPCL fully redeemed its 6.27% unsecured NCDs at maturity on October 26, 2026, repaying Rs 10,000.00 Crore. The series is now fully retired with no outstanding amount.
- Value
- ₹10,000 Cr
Bharat Petroleum Corporation Debt & Borrowing: ₹62.7 Cr
BPCL paid Rs 62.70 Crore yearly interest on its 6.27% unsecured NCDs on the due date. No payment delay was reported.
- Value
- ₹62.70 Cr
Bharat Petroleum Corporation Debt & Borrowing: ₹1,000 Cr
BPCL confirmed payment of Rs 6,270 lakh interest and full redemption of Rs 1,00,000 lakh on its 6.27% NCDs (ISIN INE322J08040) on 26 October 2026. This is a debt servicing and redemption event with no new capital raised.
- Value
- ₹1,000 Cr
Bharat Petroleum Corporation Earnings Call Transcript: Key Takeaways
BPCL managed a resilient Q2 despite crude volatility and high freight, benefiting from strong distillate yields and Russian discounts, though marketing margins faced significant under-recovery pressure.
Other credit rating announcements
All →Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.
Shiva Cement Credit Rating
Crisil reaffirmed long-term credit ratings of A+/Stable and AA-(CE)/Stable for Shiva Cement's bank loan facilities. The ratings remain unchanged with stable outlook across all six facilities.